News

Permission to use the AstraZeneca's vaccine is in question

Permission to use the AstraZeneca's vaccine is in question
Permission to use the AstraZeneca's vaccine is in question
Subscribe to Newsletter

Permission to use the AstraZeneca's vaccine is in question

  • 3734
  • 2 min.
  • 7 connections
  • 1 quote
Permission to use the AstraZeneca's vaccine is in question

Will AstraZeneca vaccine be allowed to be used?

Despite all the assurances of AstraZeneca Pascal Soriot, CEO of AstraZeneca, that the additional study should not slow down obtaining regulatory approvals for the use of COVID-19 vaccine, a number of questions have arisen about the effectiveness of the drug being developed by the company together with Oxford University, Bloomberg writes.

In order to clarify the uncertainty and confusion surrounding the positive results of the current study, the vaccine will be sent to a new trial to confirm its stated 90 per cent effectiveness.


It should be noted that after Astra Zeneca admitted that the lower dosage level, which in fact proved to be even more effective, was the result of a mistake. A day after the release of the 90 percent vaccine efficacy data, the head of the American vaccine programme Operation Warp Speed said that the higher efficacy regime had been tested on younger, and therefore stronger, patients.

P. Soriot said: "I think there will be another global study, but it will go faster because we know that the effectiveness of the drug is high, so we need fewer patients".

Also, the UK Health Secretary, Matthew Hancock, has asked the regulator to issue a permit earlier than his EU colleague and to approve the delivery of AstraZeneca vaccine to speed up its introduction in the country before the end of the year, when the UK will end its transition period after Brexit.

The current rule allows the UK regulator to allow temporary deliveries of the vaccine even before the European Medicines Agency authorises it, if the data on the vaccine tests are sufficiently reliable. It is now up to the results of the tests alone.

With regard to authorising the vaccine in the USA, the Food and Drug Administration (FDA) may delay approval, firstly because the vaccine tests are not carried out in America, and secondly because there are questions about the results.

Astra shares fell 0.8 per cent on Friday morning on the London Stock Exchange, resulting in a fall of around 8 per cent this week.

Persons2 and Companies5 in the news

Tags:
Section: business

Related news

Last news

Quotes

All

John Malkovich Wins Best Actor at Venice Film Festival Amid Oscar Buzz

MALKOVICH John
MALKOVICH John

I am humbled to be chosen for this award, which has been given to so many wonderful actors over the past 83 iterations of the Venice Film Festival

Jimmy Kimmel Slams FCC ‘Threats’ as White House Fires Back

KIMMEL James
KIMMEL James

This is yet another attack on free speech, something that has become all too familiar for us at the show, for us in the country

BBC Line of Duty star Martin Compston teases new series and says 'this is the end'

COMPSTON Martin
COMPSTON Martin

It's for Jed to say, it's not for me to say whether the show will ever end but I think it's fair to say that this is the end of the story arc that's been building since series one. Everything will come to a head on this one.

Game of Thrones’ Maisie Williams Addresses Arya Stark Spinoff Rumors and Possible Return

WILLIAMS Margaret
WILLIAMS Margaret

I don’t know, really. She would have to be developed in some way because I feel like I’ve changed so much

Mariska Hargitay Honors Gloria Steinem in Emotional Emmys Speech for ‘My Mom Jayne’

HARGITAY Mariska
HARGITAY Mariska

I just want that invitation to go out, especially to women

Buy this ad slot 240×400 slot is free Write →

Events

All

Hug Your Boss Day 13 September

There is no need to feel bad if you forget about National Hug Your Boss Day on February 4. It is a day to show appreciation and gratitude to your supe ...

Read more >